FDA — authorised 28 July 1947
- Application: NDA006071
- Marketing authorisation holder: ROCHE
- Local brand name: BEROCCA PN
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Pharmacological ascorbate in United States
FDA authorised Pharmacological ascorbate on 28 July 1947
Marketing authorisations
FDA — authorised 20 February 1953
- Application: NDA008809
- Marketing authorisation holder: HOSPIRA
- Local brand name: M.V.I.-12 ADULT
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 13 July 1982
- Application: NDA018439
- Marketing authorisation holder: WATSON LABS
- Local brand name: MVC PLUS
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 29 December 1993
- Application: NDA020176
- Marketing authorisation holder: HOSPIRA
- Local brand name: VITAPED
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA — authorised 21 February 2001
- Application: NDA021265
- Marketing authorisation holder: SANDOZ CANADA INC
- Local brand name: INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)
- Indication: INJECTABLE — INTRAVENOUS
- Status: approved
FDA — authorised 30 January 2004
- Application: NDA021625
- Marketing authorisation holder: HOSPIRA
- Local brand name: M.V.I. ADULT
- Indication: INJECTABLE — INTRAVENOUS
- Status: approved
FDA — authorised 2 October 2017
- Application: NDA209112
- Marketing authorisation holder: MCGUFF
- Local brand name: ASCOR
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
FDA — authorised 7 August 2025
- Application: ANDA217131
- Marketing authorisation holder: FRESENIUS KABI USA
- Local brand name: ASCORBIC ACID
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
FDA — authorised 21 April 2026
- Application: ANDA210456
- Marketing authorisation holder: APOTEX
- Local brand name: MULTIPLE VITAMINS INJECTION PEDIATRIC (PHARMACY BULK PACKAGE)
- Indication: INJECTABLE — INTRAVENOUS
- Status: approved
FDA — authorised 21 April 2026
- Application: ANDA210671
- Marketing authorisation holder: APOTEX
- Local brand name: MULTIPLE VITAMINS INJECTION PEDIATRIC
- Indication: INJECTABLE — INTRAVENOUS
- Status: approved
FDA
- Application: NDA018933
- Marketing authorisation holder: TELIGENT
- Local brand name: M.V.I.-12 LYOPHILIZED
- Indication: INJECTABLE — INJECTION
- Status: approved
Frequently asked questions
Is Pharmacological ascorbate approved in United States?
Yes. FDA authorised it on 28 July 1947; FDA authorised it on 20 February 1953; FDA authorised it on 13 July 1982.
Who is the marketing authorisation holder for Pharmacological ascorbate in United States?
ROCHE holds the US marketing authorisation.